If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthern Venture Trust Regulatory News (NVT)

Share Price Information for Northern Venture Trust (NVT)

Share Price is delayed by 15 minutes
Get Live Data
55.00    0.00 (0.00%)
Bid:
53.50
Ask:
56.50
Spread: 3.00 (5.607%)
Market Cap: £143.96m
NVT Live PriceLast checked at - London Stock Exchange

Intraday Northern Venture Trust Share Chart

Net Asset Value(s)

20 Jul 2021 16:00

Net Asset Value(s)

20 JULY 2021

 

NORTHERN VENTURE TRUST PLC

 

UNAUDITED NET ASSET VALUE AS AT 30 JUNE 2021

 

Northern Venture Trust PLC (“the Company”) is a Venture Capital Trust (“VCT”) launched in 1995 and advised by Mercia Fund Management Limited. The Company’s objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.

 

The unaudited net asset value per ordinary share as at 30 June 2021 was 80.9 pence (31 March 2021 (un-audited 79.8 pence). The net asset value is stated before deducting the interim dividend of 2.0 pence per share and the second interim (special) dividend of 6.0 pence per share in respect of the year ending 30 September 2021, which will be paid to eligible shareholders on 20 August 2021.

 

For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 30 June 2021 and unquoted investments are carried at fair value as at 30 June 2021 as determined by the directors.

 

New Investments:

During the three months ended 30 June 2021 one new venture capital investment was completed.

 

Name of company Business activity Amount invested £000
Naitive Technologies LimitedArtificial intelligence enabled medical diagnostics787

In addition to the new investment above £494,000 was invested in three existing portfolio companies during the quarter.

 

Realisations:

Name of company Sale proceeds Original cost Carrying value at 30 September 2020
 £000£000£000
Entertainment Magpie9,4431,3725,647
Soda Software Labs1,2561,472747
Avid Technology3521,873300

 

The number of ordinary shares in issue at 30 June 2021 was 158,952,520. During the three months ended 30 June 2021 no shares were allotted and no shares were purchased for cancellation during the period.

 

Enquiries:

Simon John/James Bryce, NVM Private Equity LLP – 0191 244 6000

 

 

Martin Glanfield, Chief Financial Officer, Mercia Asset Management PLC – 0330 223 1430

Website: www.mercia.co.uk

 

Neither the contents of the NVM Private Equity LLP or the Mercia Asset Management PLC website, nor the contents of any website accessible from hyperlinks on the NVM Private Equity LLP or Mercia Asset Management PLC website (or any other website), are incorporated into, or forms part of, this announcement.

Date   Source Headline
20th Aug 202112:00 pmGNWDirector/PDMR Shareholding
20th Aug 202112:00 pmGNWDirector/PDMR Shareholding
20th Jul 20214:00 pmGNWNet Asset Value(s)
19th Jul 20213:00 pmGNWStatement regarding intention to fund raise
13th Jul 20213:45 pmGNWHalf-year report
5th Jul 202112:45 pmGNWTransaction in Own Shares
23rd Jun 20213:00 pmGNWHalf-year report
22nd Apr 20219:00 amGNWAdmission to AIM of musicMagpie plc
8th Apr 202111:35 amGNWInvestee company - intention to float
1st Apr 20213:30 pmGNWTotal Voting Rights
30th Mar 20213:45 pmGNWTransaction in Own Shares
8th Mar 202112:45 pmGNWTransaction in Own Shares
25th Feb 20215:20 pmGNWNet Asset Value(s)
1st Feb 20214:50 pmGNWTotal voting rights
22nd Jan 202110:15 amGNWDirector/PDMR Shareholding
22nd Jan 202110:10 amGNWDirector/PDMR Shareholding
22nd Jan 202110:10 amGNWDirector/PDMR Shareholding
22nd Jan 202110:00 amGNWIssue of Equity
15th Jan 20212:00 pmGNWResult of Meeting
18th Dec 20204:00 pmGNWTransaction in Own Shares
18th Dec 20202:30 pmGNWAnnual Financial Report and Circular
1st Dec 20204:15 pmGNWAnnual Financial Report
30th Sep 20205:00 pmGNWTotal voting rights
28th Sep 20205:50 pmGNWTransaction in Own Shares
28th Aug 202011:12 amGNWDirector/PDMR Shareholding
28th Aug 202011:10 amGNWDirector/PDMR Shareholding
28th Aug 202011:00 amGNWIssue of Equity and Total Voting Rights
31st Jul 20202:30 pmGNWNet Asset Value
31st Jul 20202:30 pmGNWTotal voting rights
31st Jul 20202:30 pmGNWHalf-year report
16th Jul 202012:00 pmGNWTransaction in Own Shares
8th Jul 20204:25 pmGNWHalf-year report
17th Jun 202012:00 pmGNWPublication of updated and amended reporting timetable
30th Apr 20204:00 pmGNWTotal voting rights
27th Apr 20208:00 amGNWForm 8.3 - Collagen Solutions PLC
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
6th Apr 20202:30 pmGNWDirector/PDMR notification
6th Apr 20202:30 pmGNWDirector/PDMR Shareholding
3rd Apr 202012:30 pmGNWIssue of Equity
31st Mar 20204:30 pmGNWTotal voting rights
31st Mar 20204:00 pmGNWPublication of a supplementary prospectus
30th Mar 202011:20 amGNWTransaction in Own Shares
25th Mar 20202:45 pmGNWNet Asset Value
25th Feb 20203:30 pmGNWTransaction in Own Shares
20th Feb 20209:30 amGNWOffer Update
17th Feb 20203:00 pmGNWNet Asset Value(s)
10th Jan 20202:30 pmGNWPublication of Prospectus
8th Jan 20201:30 pmGNWResult of Meeting
31st Dec 20199:00 amGNWTotal voting rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.